Create a free account

B3 · BRL

HYPE3

Hypera S.A.

R$24.48+3.16% (R$0.75)
Day's range
R$23.74 – R$24.71
Day's volume
R$134.3m
52-week range
R$19.88 – R$27.51

Follow HYPE3 on Fuolio

See how HYPE3 weighs in your net worth, what it has paid you and how far it is from your target allocation.

Create a free account

HYPE3 in numbers

Market cap
R$17.2bn
P/E
9.87
P/B
1.19
Dividend yield (12m)
4.42%
Net debt/EBITDA
4.40

The 12-month dividend yield of HYPE3 is 4.42%, above its 5-year average of 4.15%.

HYPE3 price history

01/10/202530/09/2026
Compare with

HYPE3 risk and return

Monthly closes adjusted for splits and distributions.

Metric12 months36 months60 months
Return-0.72%-7.17%+6.69%
Volatility (annualised)23.55%29.30%30.09%
Largest drawdown-19.50%-47.06%-61.31%
Positive months6/1219/3632/60

How much did investing in HYPE3 return?

R$1,000.00 invested on 01/09/2021 would be worth R$937.15 today.

Value today in HYPE3
R$937.15
Return over the period
-6.29%
Return per year
-1.29%
In the Ibovespa
R$1,657.66

With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.

HYPE3 fundamentals

Valuation

  • P/E
    9.87
  • P/B
    1.19
  • EV/EBITDA
    10.45
  • EV/EBIT
    11.83
  • EV/Revenue
    3.37
  • P/EBIT
    6.85
  • P/S
    1.95
  • P/OCF
    5.94
  • P/FCF
    7.32
  • Earnings yield
    8.45%
  • PEG ratio
    0.07
  • Earnings per share
    R$2.48
  • Book value per share
    R$20.50

Debt

  • Net debt
    R$12.5bn
  • Net debt/EBITDA
    4.40
  • Net debt/Equity
    0.87
  • Debt/Equity
    0.98
  • Current ratio
    1.86
  • Quick ratio
    1.26
  • Cash ratio
    0.49

Efficiency

  • Gross margin
    61.17%
  • EBITDA margin
    32.27%
  • Operating margin
    28.52%
  • Net margin
    19.76%
  • Asset turnover
    0.35

Profitability

  • ROE
    12.10%
  • ROA
    6.87%
  • ROIC
    9.33%
  • Payout
    43.61%

Growth

  • Revenue CAGR (5 years)
    12.46%
  • Earnings CAGR (5 years)
    3.98%
  • Revenue growth (year)
    3.45%
  • Earnings growth (year)
    -10.86%
  • Revenue growth (quarter)
    32.38%
  • Earnings growth (quarter)
    135.13%

What is HYPE3's fair price?

Two classic value formulas, with today's numbers. The current price is R$24.48.

Graham's fair price
R$33.82
38.17% above the price

√(22.50 × R$2.48 × R$20.50)

Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.

Bazin's ceiling price
R$18.02
26.38% below the price

R$1.08 (5-year average) ÷ 6%

Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.

Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.

HYPE3 indicators by year

Multiples at each year's closing price; margins and returns from that year's accounts.

Indicator20252024202320222021202020192018
P/E13.888.5413.7416.8713.4716.7519.3816.90
P/B1.320.951.972.691.822.352.592.31
EV/EBITDA15.4012.8013.8416.0613.3718.3818.6713.66
Dividend yield6.20%6.81%0.86%2.73%4.15%3.12%2.71%3.05%
Earnings per shareR$1.70R$2.12R$2.60R$2.68R$2.10R$2.04R$1.84R$1.79
Book value per shareR$17.79R$19.11R$18.18R$16.82R$15.52R$14.59R$13.78R$13.08
ROE9.54%11.08%14.31%15.92%13.53%14.02%13.36%13.66%
ROIC6.30%6.61%9.32%10.09%9.68%9.40%12.53%15.80%
Gross margin59.04%58.86%63.12%63.10%64.05%64.30%63.30%71.56%
EBITDA margin27.04%28.23%34.82%35.14%35.40%35.23%36.61%35.41%
Net margin15.53%18.02%20.82%22.48%22.40%31.67%35.33%30.33%
Net debt/EBITDA7.437.345.625.264.843.32-0.04-0.82

HYPE3 financial statements

Line202520242023202220212020
Net revenueR$7.7bnR$7.4bnR$7.9bnR$7.5bnR$5.9bnR$4.1bn
Cost of sales-R$3.2bn-R$3.1bn-R$2.9bn-R$2.8bn-R$2.1bn-R$1.5bn
Gross profitR$4.5bnR$4.4bnR$5bnR$4.8bnR$3.8bnR$2.6bn
EBITDAR$2.1bnR$2.1bnR$2.8bnR$2.7bnR$2.1bnR$1.4bn
EBITR$1.8bnR$1.8bnR$2.5bnR$2.5bnR$2bnR$1.3bn
Net finance result-R$864.2m-R$840.7m-R$1bn-R$871.6m-R$323.7m-R$75.4m
Profit before taxR$900.1mR$979.2mR$1.5bnR$1.6bnR$1.6bnR$1.2bn
Income taxR$290.8mR$353.8mR$141.6mR$95.3m-R$26.6mR$78.2m
Net incomeR$1.2bnR$1.3bnR$1.6bnR$1.7bnR$1.3bnR$1.3bn

Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.

HYPE3 against its sector

The same indicators for the company's other shares and the sector's largest stocks.

StockP/EP/BDividend yield (12m)ROEMarket cap
HYPE3Hypera9.871.194.42%12.10%R$17.2bn
BLAU3BLAU FARMACÊUTICA S.A.10.411.048.65%10.02%R$2.4bn
OFSA3OUROFINO S.A.5.881.685.01%28.55%R$1.4bn
BIOM3BIOMM S.A.26.852.500.00%9.33%R$814.3m
BALM3BAUMER S.A.9.761.2821.91%13.16%R$178.7m
BALM4BAUMER S.A.6.420.8433.31%13.16%R$178.7m

Does HYPE3 pay dividends?

Announced payments
TypeLast day to ownPaymentPer share
Interest on equity26/12/202530/12/2026R$0.29
Interest on equity26/09/202530/12/2026R$0.29
Interest on equity26/06/202531/12/2026R$0.29
Interest on equity28/09/202631/12/2027R$0.26
Interest on equity26/06/202631/12/2027R$0.26
Interest on equity31/03/202631/12/2027R$0.26

Dividend yield per year

  • 5.42%2017
  • 3.05%2018
  • 2.71%2019
  • 3.12%2020
  • 4.15%2021
  • 2.73%2022
  • 0.86%2023
  • 6.81%2024
  • 6.20%2025
  • 0.00%2026
Payment history
TypeLast day to ownPaymentPer share
Interest on equity27/03/202517/12/2025R$0.29
Interest on equity27/12/202417/12/2025R$0.17
Dividend27/12/202417/12/2025R$0.12
Interest on equity23/09/202417/12/2025R$0.20
Interest on equity24/07/202417/12/2025R$0.10
Interest on equity21/06/202417/12/2025R$0.10
Interest on equity23/05/202417/12/2025R$0.10
Interest on equity23/04/202417/12/2025R$0.10
Interest on equity21/03/202417/12/2025R$0.10
Interest on equity22/02/202417/12/2025R$0.10
Interest on equity01/02/202417/12/2025R$0.10
Interest on equity26/12/202327/12/2024R$0.31
See all 46 distributions
Earlier distributions
TypeLast day to ownPaymentPer share
Interest on equity27/09/202327/12/2024R$0.31
Interest on equity03/07/202327/12/2024R$0.31
Interest on equity29/03/202327/12/2024R$0.31
Interest on equity22/12/202202/01/2023R$0.31
Interest on equity28/12/202107/01/2022R$0.31
Interest on equity27/09/202107/01/2022R$0.31
Interest on equity22/07/202107/01/2022R$0.31
Interest on equity26/03/202107/01/2022R$0.31
Interest on equity28/12/202007/01/2021R$0.29
Interest on equity23/10/202007/01/2021R$0.29
Interest on equity26/06/202007/01/2021R$0.29
Interest on equity27/03/202007/01/2021R$0.29
Interest on equity02/10/201931/01/2020R$0.26
Interest on equity02/07/201930/01/2020R$0.26
Interest on equity11/04/201930/01/2020R$0.23
Interest on equity11/04/201930/01/2020R$0.03
Interest on equity23/12/201907/01/2020R$0.30
Interest on equity02/10/201825/06/2019R$0.20
Interest on equity03/07/201825/06/2019R$0.21
Interest on equity05/04/201811/01/2019R$0.21
Interest on equity21/12/201809/01/2019R$0.15
Interest on equity21/12/201809/01/2019R$0.20
Interest on equity28/12/201709/01/2018R$0.92
Other23/06/201703/07/2017R$1.30
Dividend19/04/201702/05/2017R$0.05
Dividend15/02/201724/02/2017R$0.60
Dividend27/07/201615/08/2016R$0.25
Dividend02/05/201620/05/2016R$0.21
Dividend14/04/201620/05/2016R$0.04
Dividend30/04/201310/05/2013R$0.16
Interest on equity28/09/2022—R$0.31
Interest on equity27/06/2022—R$0.31
Interest on equity28/03/2022—R$0.31
Dividend29/04/2011—R$0.12
Splits, share consolidations and bonus shares
EventLast day to ownRatio
Split30/12/20092 for 1

About Hypera

Sector
Consumo Não Cíclico
Segment
Medicamentos e Outros Produtos
Listing segment
Novo Mercado
Tag along
100.00%
Free float
42.05%
Shares issued
704.01m ordinary
Average daily trading
R$67.2m
Ibovespa weight
0.27%
Listed since
18/04/2008
CNPJ
02.932.074/0001-91

A Hypera S.A., listada na B3 sob o ticker HYPE3, é uma farmacêutica brasileira com foco em medicamentos de prescrição, isentos de prescrição e marcas de saúde. A companhia foi fundada em 2001 e, após reestruturações de portfólio, consolidou atuação prioritária no setor farmacêutico. O modelo de negócios combina desenvolvimento, produção, marketing e distribuição de produtos para diferentes classes terapêuticas, com presença forte em canais de varejo e prescrição médica. A empresa opera marcas consolidadas no mercado doméstico e mantém estrutura industrial e comercial em escala nacional. Nos últimos anos, a estratégia incluiu aquisições de portfólios e marcas para ampliar participação em categorias de maior rentabilidade, além de ganhos de eficiência fabril e logística. O foco permanece em expansão de receita por mix de produtos e execução comercial. No contexto do mercado brasileiro, a Hypera está entre as maiores companhias farmacêuticas de capital aberto do país, com exposição predominante ao consumo interno de medicamentos e produtos de saúde.

Investor website
ShareholdersAs of 31/12/2026, from the Formulário de Referência filed with the CVM.
ShareholderOrdinaryPreferredTotal
JOÃO ALVES DE QUEIROZ FILHOControlling25.93%0.00%25.93%
Votorantim S.A.Controlling15.78%0.00%15.78%
Maiorem S.A. de C.V.Controlling13.26%0.00%13.26%
NEGOTIO MAGNI S.A DE C.V1.48%0.00%1.48%
ALVARO STAINFELD LINKControlling0.12%0.00%0.12%
Outros43.43%0.00%43.43%
Ações Tesouraria0.00%0.00%0.00%

Questions about HYPE3

How much is HYPE3 today?

HYPE3 is at R$24.48 (3.16% on the day), last traded on 30/09/2026.

How much did HYPE3 pay in dividends in 2025?

HYPE3 paid R$1.46 per share in 2025, a dividend yield of 6.20%.

When is the next HYPE3 dividend?

The next announced payment is R$0.29 per share on 30/12/2026.

What are the P/E and P/B of HYPE3?

HYPE3 trades at a P/E of 9.87 and a P/B of 1.19.

How much did HYPE3 return in 12 months?

HYPE3 returned -0.72% in 12 months, with annualised volatility of 23.55% and a largest drawdown of -19.50%.

What sector is HYPE3 in?

Hypera is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.